Anti-p200 pemphigoid: Diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease

Journal of the American Academy of Dermatology

Volumn 46, Issue 5, 2002, Pages 786-789

  Egan, Conleth A ^a   Yee, Carole ^a   Zillikens, Detlef ^b   Yancey, Kim B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DAPSONE; IMMUNOGLOBULIN G; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOPATHOGENESIS; MALE; PEMPHIGOID; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0036587405     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120923     Document Type: Article

References (18)

1. Gammon WR, Briggaman RA, Inman AO, Queen LL,Wheeler CE. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984;82:139-44.
2. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310:1007-13.
3. Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA 2000;284: 350-6.
4. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990;85:812-20.
5. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank C, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996;106:1333-8.
6. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90:1628-33.
7. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, et al. Anti-epiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 1994;130:1521-9.
8. Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970;18:31533.
9. Holubar K, Wolff K, Konrad K, Beutner EH. Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. J Invest Dermatol 1975;64:220-7.
10. Dmochowski M, Hashimoto T, Bhogal BS, Black MM, Zone JJ, Nishikawa T. Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993;6:194-200.
11. Kawahara Y, Zillikens D, Yancey KB, Marinkovich MP, Nie Z, Hashimoto T, et al. Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. J Dermatol Sci 2000;23:93-102.
12. Mascaro JM Jr, Zillikens D, Giudice GJ, Caux F, Fleming MG, Katz HM, et al. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen:the first case report from the United States. J Am Acad Dermatol 2000;42:309-15.
13. Salmhofer W, Kawahara Y, Soyer HP, Kerl H, Nishikawa T, Hashimoto T. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid? Br J Dermatol 1997;137:599-604.
14. Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993;11:535-47.
15. Chan LS, Fine JD, Briggaman RA, Woodley DT, Hammerberg C, Drugge RJ, et al. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 1993;101:262-7.
16. Zillikens D, Ishiko A, Jonkman MF, Chimanovitch I, Shimizu H, Hashimoto T, et al. Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol 2000;143:1043-9.
17. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995;105:543-8.
18. Lazarova Z, Hsu R, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2). Br J Dermatol 1998;139:791-7.